Real-world Effectiveness of Ustekinumab in Participants Suffering From Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis) With Extra-intestinal Manifestations or Immune-mediated Inflammatory Diseases
Clinical trial NCT03606499 · COMPLETED
Trial details
- NCT number
- NCT03606499
- Sponsor
- Janssen Cilag S.A.S.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-09-26
- Primary completion
- 2023-03-17
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.